What are you looking for?
All Filters
Therapeutic Area
Therapeutic Area
Date Published
Date published

GILENYA®


Indications


Gilenya is indicated as monotherapy for the treatment of adult patients and paediatric patients of 10 years of age and above with the relapsing-remitting form of multiple sclerosis to reduce the frequency of clinical exacerbations and to delay the progression of physical disability.

Package Insert

Novartis Risk Management Plan (RMP) Educational Material for Patients
HSA Approved RMP - Patient, Parent and Caregiver Medication Guide

HSA Approved RMP

Patient, Parent and Caregiver Medication Guide

PDF
Download
HSA Approved RMP - Patient Pregnancy Guide

HSA Approved RMP

Patient Pregnancy Guide

PDF
Download
Novartis Risk Management Plan (RMP) Educational Material for Physicians
HSA Approved RMP - HCP Checklist

HSA Approved RMP

HCP Checklist

PDF
Download